Cargando…
High Levels of Treatment Success and Zero Relapse in Multidrug-Resistant Tuberculosis Patients Receiving a Levofloxacin-Based Shorter Treatment Regimen in Vietnam
Vietnam has been using a levofloxacin-based shorter treatment regimen (STR) for rifampicin resistant/multidrug-resistant tuberculosis (RR/MDR-TB) patients since 2016 on a pilot basis. This regimen lasts for 9–11 months and is provided to RR/MDR-TB patients without second-line drug resistance. We rep...
Autores principales: | Anh, Le T. N., M. V. Kumar, Ajay, Ramaswamy, Gomathi, Htun, Thurain, Thanh Hoang Thi, Thuy, Hoai Nguyen, Giang, Quelapio, Mamel, Gebhard, Agnes, Nguyen, Hoa Binh, Nguyen, Nhung Viet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157716/ https://www.ncbi.nlm.nih.gov/pubmed/32164231 http://dx.doi.org/10.3390/tropicalmed5010043 |
Ejemplares similares
-
An Innovative Public–Private Mix Model for Improving Tuberculosis Care in Vietnam: How Well Are We Doing?
por: Do Thu, Thuong, et al.
Publicado: (2020) -
Safety and effectiveness of all-oral and injectable-containing, bedaquiline-based long treatment regimen for pre-XDR tuberculosis in Vietnam
por: Nguyen, Thi Mai Phuong, et al.
Publicado: (2022) -
Challenges in detection and treatment of multidrug resistant tuberculosis patients in Vietnam
por: Hoang, Thuy Thi Thanh, et al.
Publicado: (2015) -
Adverse events in the treatment of MDR-TB patients within and outside the NTP in Pham Ngoc Thach hospital, Ho Chi Minh City, Vietnam
por: Hoa, Nguyen Binh, et al.
Publicado: (2015) -
Predictors of treatment outcomes among patients with multidrug-resistant tuberculosis in Vietnam: a retrospective cohort study
por: Wrohan, Ian, et al.
Publicado: (2022)